HA
HALOZYME THERAPEUTICS, INC.
Nasdaq : HALOHealthcare · Biological Products, (No Diagnostic Substances)
Mkt Cap$12.76BShares Out113.50M30d Avg Vol24.74MShort Int—Short Float—IPOMar 12, 2004
▲+0.74%
$9.51
–
| Form | Description | Filed |
|---|---|---|
| 4 | Statement of Changes in Beneficial Ownership | Jun 30, 2026 |
| SC 13G/A | Beneficial Ownership Report (Amended) | Jun 30, 2026 |
| 10-Q | Quarterly Report | Jun 30, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 27, 2026 |
| SD | Specialized Disclosure Report | Jun 27, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 25, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 23, 2026 |
| 8-K | 1.01,9.01 | Jun 23, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 23, 2026 |
| 8-K | Current Report | Jun 23, 2026 |
| 4 | Statement of Changes in Beneficial Ownership1 | Jun 23, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 18, 2026 |
| 4 | Statement of Changes in Beneficial Ownership4 | Jun 15, 2026 |
| 3 | Initial Statement of Beneficial Ownership | Jun 10, 2026 |
| 8-K | 7.01 | Jun 10, 2026 |
| 424B5 | Prospectus Supplement | Jun 10, 2026 |
| 13F-HR | Institutional Holdings Report | Jun 5, 2026 |
| FWP | SEC Filing5 | Jun 3, 2026 |
| N-PX | Proxy Voting Record | May 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 24, 2026 |
| 8-K | 8.01,9.01 | May 24, 2026 |
| SC 13G | Beneficial Ownership Report | May 23, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 21, 2026 |
1-25 of 210 filings
…